US$ 25.92
igf 1 lr3 clinical trial IGF-1 Receptor Grade 1mg | USA | CAS 946870-92-4 IGF-1 LR3 Research: Extended Half-Life
Description
Lakey-Beitia, J., Berrocal, R., Rao, K

A., Nasr Esfahani, M

S2CID 249382539

10.1186/s12958-018-0406-2 66

501 Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the dysfunction of upper and lower motor neurons
